TherapeuticsMD, Inc. (TXMD) stock
TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 12/3030% below fair value
$1.82−0.03 (-1.62%)
Close on Nov 12, 2026Market cap $21.07MP/E –Yield –
TherapeuticsMD total assets
Total assets on the balance sheet at the end of each period.
TherapeuticsMD's total assets was $37.53M at Jun 30, 2026. For fiscal 2025 it was $37.66M, down 3.0% from the year before. Over ten years it grew -6.5% a year on average. The highest annual figure on record is $265.99M in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.66M | -3.0% |
| FY2024 | Dec 31, 2024 | $38.82M | -10.4% |
| FY2023 | Dec 31, 2023 | $43.31M | -52.1% |
| FY2022 | Dec 31, 2022 | $90.46M | -46.6% |
| FY2021 | Dec 31, 2021 | $169.47M | -6.7% |
| FY2020 | Dec 31, 2020 | $181.61M | -31.7% |
| FY2019 | Dec 31, 2019 | $265.99M | +25.5% |
| FY2018 | Dec 31, 2018 | $211.98M | +48.0% |
| FY2017 | Dec 31, 2017 | $143.23M | +0.5% |
| FY2016 | Dec 31, 2016 | $142.47M | +93.2% |
| FY2015 | Dec 31, 2015 | $73.73M | +24.8% |
| FY2014 | Dec 31, 2014 | $59.08M | -4.7% |
| FY2013 | Dec 31, 2013 | $62.02M | +946.5% |
| FY2012 | Dec 31, 2012 | $5.93M | +311.9% |
| FY2011 | Dec 31, 2011 | $1.44M | +207.8% |
| FY2010 | Dec 31, 2010 | $467.42K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $37.53M | -2.5% |
| Q1 FY2026 | Mar 31, 2026 | $37.58M | -1.7% |
| Q4 FY2025 | Dec 31, 2025 | $37.66M | -3.0% |
| Q3 FY2025 | Sep 30, 2025 | $38.67M | -2.2% |
| Q2 FY2025 | Jun 30, 2025 | $38.50M | -4.0% |
| Q1 FY2025 | Mar 31, 2025 | $38.24M | -9.2% |
| Q4 FY2024 | Dec 31, 2024 | $38.82M | -10.4% |
| Q3 FY2024 | Sep 30, 2024 | $39.55M | -21.7% |
| Q2 FY2024 | Jun 30, 2024 | $40.13M | -25.3% |
| Q1 FY2024 | Mar 31, 2024 | $42.09M | -29.4% |
| Q4 FY2023 | Dec 31, 2023 | $43.31M | -52.1% |
| Q3 FY2023 | Sep 30, 2023 | $50.49M | -62.3% |
| Q2 FY2023 | Jun 30, 2023 | $53.69M | -63.3% |
| Q1 FY2023 | Mar 31, 2023 | $59.60M | -55.3% |
| Q4 FY2022 | Dec 31, 2022 | $90.46M | -46.6% |
| Q3 FY2022 | Sep 30, 2022 | $133.91M | -36.1% |
| Q2 FY2022 | Jun 30, 2022 | $146.20M | -30.6% |
| Q1 FY2022 | Mar 31, 2022 | $133.38M | -44.3% |
| Q4 FY2021 | Dec 31, 2021 | $169.47M | -6.7% |
| Q3 FY2021 | Sep 30, 2021 | $209.63M | +18.2% |
| Q2 FY2021 | Jun 30, 2021 | $210.60M | +2.5% |
| Q1 FY2021 | Mar 31, 2021 | $239.31M | -10.9% |
| Q4 FY2020 | Dec 31, 2020 | $181.61M | -31.7% |
| Q3 FY2020 | Sep 30, 2020 | $177.29M | -29.1% |
| Q2 FY2020 | Jun 30, 2020 | $205.54M | -16.6% |
| Q1 FY2020 | Mar 31, 2020 | $268.64M | +47.7% |
| Q4 FY2019 | Dec 31, 2019 | $265.99M | +25.5% |
| Q3 FY2019 | Sep 30, 2019 | $249.96M | +5.6% |
| Q2 FY2019 | Jun 30, 2019 | $246.55M | +43.4% |
| Q1 FY2019 | Mar 31, 2019 | $181.89M | +47.9% |
| Q4 FY2018 | Dec 31, 2018 | $211.98M | +48.0% |
| Q3 FY2018 | Sep 30, 2018 | $236.75M | +47.6% |
| Q2 FY2018 | Jun 30, 2018 | $171.90M | +60.8% |
| Q1 FY2018 | Mar 31, 2018 | $122.96M | -1.2% |
| Q4 FY2017 | Dec 31, 2017 | $143.23M | +0.5% |
| Q3 FY2017 | Sep 30, 2017 | $160.36M | +1.0% |
| Q2 FY2017 | Jun 30, 2017 | $106.88M | – |
| Q1 FY2017 | Mar 31, 2017 | $124.42M | – |
| Q4 FY2016 | Dec 31, 2016 | $142.47M | – |
| Q3 FY2016 | Sep 30, 2016 | $158.82M | – |
See a number that looks wrong?